Fill out the information below, and someone from Catalyst will reach out shortly

*Required fields.

First Name*

Last Name*

NPI Number:

Business/Practice Email Address*

Zip*

Phone*

Reasons for contact (select all that apply)*:

I want information on a free LEMS test:

I may have an adult LEMS patient:

I want more FIRDAPSE information:

I want patient savings information:

I want to schedule time with LEMS expert:

I want information on FIRDAPSE NAT2 Registry:

Type of Healthcare Provider:

LEMS experience:

Receive the latest news about FIRDAPSE:

Catalyst Pharmaceuticals respects your personal information. The information you provide may be used to send you health-related materials and to develop products, services, and programs. Catalyst Pharmaceuticals or third parties working on our behalf will not sell or rent personal health information. Your information will only be used in accordance with the Catalyst Privacy Policy.

If you later wish to opt out of receiving this information, you may click on the included opt‑out link in future communications.

By completing this registration, you confirm that you are 18 years of age or older and a US resident.

INDICATION AND IMPORTANT SAFETY INFORMATION

INDICATIONS AND USAGE:

FIRDAPSE is a potassium channel blocker indicated for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults.

CONTRAINDICATIONS

FIRDAPSE is contraindicated in patients with:

A history of seizures
Hypersensitivity to amifampridine phosphate or another aminopyridine

WARNINGS AND PRECAUTIONS

Seizures: FIRDAPSE can cause seizures. Consider discontinuation or dose-reduction of FIRDAPSE in patients who have a seizure while on treatment. FIRDAPSE is contraindicated in patients with a history of seizures.

Hypersensitivity: If a hypersensitivity reaction such as anaphylaxis occurs, FIRDAPSE should be discontinued and appropriate therapy initiated.

ADVERSE REACTIONS

The most common (> 10%) adverse reactions are: paresthesia, upper respiratory tract infection, abdominal pain, nausea, diarrhea, headache, elevated liver enzymes, back pain, hypertension, and muscle spasms.

To report SUSPECTED ADVERSE REACTIONS, contact Catalyst Pharmaceuticals at 1-844-347-3277 (1-844-FIRDAPSE) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.